Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

Presentation TVT 2022

TMVR VIV: Differences Among Surgical Mitral Bioprostheses – All Paths Lead to Success

Presenter: Steven Bolling

June 09, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Todd Neale

February 02, 2022

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Advertisement

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

TMVR VIV: Differences Among Surgical Mitral Bioprostheses – All Paths Lead to Success

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content